Profile of Crisis Response of District Health / Disaster Risk: District of South Central Timor, Indonesia
Profile of Crisis Response of District Health or Disaster Risk in District of North Central Timor, Indonesia
Profile of Crisis Response of District Health or Disaster Risk at East Halmahera District, Indonesia
Profile of Health Crisis Response within District with High Risk of Disaster : West Halmahera-District, Indonesia
Profile of Health Crisis Response of District with High Risk of Natural Disaster : District of North Kolaka, Indonesia
Profile of Health Crisis Response within District with High Risk of Natural Disaster : District of Lebong, Indonesia
Profile of Health Crisis Response within District with High Risk of Natural Disaster : District of North Halmahera, Indonesia
Profile of Health Crisis Response within District with High Risk of Natural Disaster : District of Sambas, Indonesia
Profile of Health Crisis Response within District with High Risk of Natural Disaster : District of Landak, Indonesia
Profile of Health Crisis Response within District with High Risk of Disaster : District of Central Bengkulu, Indonesia
Profile of Health Crisis Response within District with High Disaster Risk: District of Kapuas, Indonesia
Profile of Health Crisis Response within District with High Risk of Disaster : District of North Bengkulu, Indonesia
Profile of Health Crisis Response within District with High Risk of Disaster : District of Muna, Indonesia
Profile of Health Crisis Response within District with High Risk of Natural Disaster : District of Morotai Island, Indonesia
Profile of Health Crisis Response within District with High Risk of Natural Disaster : District of Middle Halmahera, Indonesia
These WHO interim recommendations for use of the BBV152 COVAXIN vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been ...updated: version 15 March 2022.
The vaccine is formulated from an inactivated SARS-CoV-2 antigen and is presented in single dose vials and multidose vials of 5, 10 and 20 doses.
more
El Niño conditions persisting during the 2015/16 planting season have caused the worst drought in 35 years in Southern Africa, resulting in a second consecutive failed harvest. This has created severe food shortages and compounded existing vulnerabilities. Since July 2016, Namibia and Botswana have... declared national drought emergencies, in addition to the declarations made earlier by Lesotho, Malawi, Swaziland and Zimbabwe. Madagascar issued a letter of solidarity with the SADC Appeal, and Mozambique has maintained a red alert in affected areas.
more
These guidelines aim to guide all health care providers in Myanmar, accommodating the situation of different settings in the context of progressive decentralization of HIV services. Notable changes from the previous edition include:
• diagnosis of HIV
• update on the initiation of ART<...br>
• new ARV drugs and regimens
• new recommendation on infant prophylaxis
• PrEP and PEP updates
• updates on co-infections and comorbidities management
It should be noted that these guidelines are meant for the operational level and are adapted and adopted in line with existing Myanmar context.
more
For applying the new operational guidance on CB-MHPSS in the field, UNICEF country offices and partners will need ready access to tools and resources that can be used to implement the programs. By bringing together resources from different contexts, the compendium makes options available to country ...offices and partners for programming.
The compendium aims to strengthen UNICEF capacity for MHPSS programming consistent with the IASC Guidelines for MHPSS in Emergencies and described by the 9 circles of support in the UNICEF operational framework.
The compendium is a compiled set of resources, already being used by UNICEF and partners, both national and international, in diverse settings.
more
Downloaded from https://aidsinfo.nih.gov/guidelines on 10/19/2019
Developed by the HHS Panel on Antiretroviral Therapy and Medical Management of Children Living with HIV—A Working Group of the Office
of AIDS Research Advisory Council (OARAC)